• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Ripple Token Sale: Whales Dump $1.91 Billion Before SEC Decision

user avatar

by Giorgi Kostiuk

2 hours ago


Recently, a significant amount of XRP tokens have been sold off by major holders, causing concern in the market ahead of the SEC's decision.

Whale Sell-Off Volume

In the past month, major XRP holders have offloaded approximately $1.91 billion worth of tokens while the price traded between $2.28 and $3.54. Since July 9, around 640 million tokens have been moved or sold; however, not all of these transfers are confirmed sales, and some may just be internal reshufflings within wallets. Analysts note that this outflow may indicate a decline in confidence among large investors.

Risk of Sharp Correction

Market analysts are raising concerns that XRP could face a stark correction. It is forecasted that if XRP drops below the crucial support level of $2.65, it could plunge another 30%, potentially hitting $2.06. This level has previously been significant, and a fall below it could trigger further fear-driven selling. Currently, XRP is barely managing to stay above the $2.65–$2.70 range.

SEC Decision and Implications

The SEC is poised to decide whether to abandon its long-standing litigation against Ripple. Should the SEC drop the case, it could bring long-overdue clarity to XRP's status in the U.S. The central question is whether XRP should be regulated as a security. This uncertainty has long been a barrier to XRP's progress. If XRP drops below the $2.65 support level, it could fall to $2 or even lower, possibly touching the 50-week EMA at $2.06.

Uncertainty surrounding the SEC's decision and the actions of major holders are causing significant concerns about XRP's future. Investors are anxiously awaiting updates from both regulators and the market.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

Other news

Eli Lilly: Financial Success Contrasted by Disappointment in Drug Trials

chest

Eli Lilly showed high revenue growth, but stock fell due to disappointing results from a new drug trial.

user avatarGiorgi Kostiuk

Investment Opportunities: FCA Allows Purchase of Crypto ETNs in the UK

chest

The UK's Financial Conduct Authority has allowed retail investors to purchase crypto ETNs, potentially transforming the digital asset market in the country.

user avatarGiorgi Kostiuk

Ethereum (ETH) and Corporate Interest: Golden Cross and Supply Shortage

chest

As Ethereum forms a golden cross, corporate interest and ETH supply shortages are on the rise.

user avatarGiorgi Kostiuk

Ripple's XRP Releases Might Have Stopped: New Report from Analysts

chest

Analytical account @XRPwallets discusses the possible cessation of XRP releases from escrow by Ripple.

user avatarGiorgi Kostiuk

US Forms Bitcoin Reserve Using Confiscated Assets

chest

The US initiates a strategic Bitcoin reserve utilizing forfeited assets without involving new taxpayer funds.

user avatarGiorgi Kostiuk

XRP Discussed Amid Corporate Adaptation and AI Price Projections

chest

XRP garners attention with corporate adaptation and AI forecasts indicating price growth by the end of August.

user avatarGiorgi Kostiuk

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.